Smokers may soon be able to break their habit with an injectable vaccine that prevents nicotine in tobacco entering the brain, where it creates a highly addictive sensation of pleasure.
The NicVAX vaccine moved closer to the market yesterday after a deal between GlaxoSmithKline and the US biotech company Nabi Pharmaceuticals, which developed the product.
